Pfizer Inc.

NYSE: PFE · Real-Time Price · USD
25.16
0.05 (0.20%)
At close: Aug 15, 2025, 3:59 PM
25.12
-0.14%
After-hours: Aug 15, 2025, 05:06 PM EDT

Pfizer Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 29, 2025 Mar 29, 2025 Dec 31, 2024 Sep 29, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Oct 1, 2023 Jul 2, 2023 Apr 2, 2023 Dec 31, 2022 Oct 2, 2022 Jul 3, 2022 Apr 3, 2022 Dec 31, 2021 Oct 3, 2021 Jul 4, 2021 Apr 4, 2021
Net Income
2.93B 2.97B 411M 4.48B 31M 3.13B -3.34B -2.39B 2.33B 5.54B 5B 8.64B 9.87B 7.88B 3.85B 8.17B 5.57B 4.88B
Depreciation & Amortization
1.63B 1.62B 1.79B 1.75B 1.73B 1.74B 1.67B 1.56B 1.57B 1.49B 1.52B 1.18B 1.18B 1.19B 1.28B 1.36B 1.33B 1.23B
Stock-Based Compensation
203M 170M 177M 274M 206M 220M 121M 151M 148M 105M 364M 135M 287M 86M 495M 293M 221M 172M
Other Working Capital
1.92B -1.92B 2.93B 879M -3.54B -3.34B 8.45B -1.2B -3.92B -5.51B 1.1B -4.11B -2.77B -730M 5.68B 6.76B 5.38B -1.33B
Other Non-Cash Items
-6.99B 156M 1.81B -193M 569M -217M 201M 5.45B -470M 184M -1.09B 59M 742M 440M -1.1B -2.01B -1.05B -609M
Deferred Income Tax
-272M -663M -396M -482M -783M -441M -1.86B -113M -873M -598M -365M 62M -1.14B -2.32B -591M -3.75B -152M 199M
Change in Working Capital
1.92B -1.92B 2.93B 879M -3.54B -3.34B 8.45B -1.2B -3.92B -5.51B 3.15B -4.11B -2.77B -730M 1.99B 6.76B 5.38B -1.33B
Operating Cash Flow
-582M 2.33B 6.72B 6.71B -1.78B 1.09B 5.24B 3.46B -1.21B 1.21B 8.58B 5.97B 8.17B 6.54B 5.91B 10.83B 11.3B 4.54B
Capital Expenditures
-618M -564M -917M -651M -637M -704M -1.04B -810M -914M -1.14B -1B -841M -751M -643M -993M -624M -540M -554M
Cash Acquisitions
-6.31B 6.31B 3.55B n/a n/a 3.49B -43.41B -2M -25M -1M -16.77B n/a n/a -6.22B -12M n/a n/a n/a
Purchase of Investments
-2.03B -6.81B -6.28B -2.67B 657M -2.02B -874M -9.21B -14.38B -6.72B 3.42B -18.79B -17.39B -9.43B -13.32B -17.71B -9.51B -7.08B
Sales Maturities Of Investments
12.92B 4.04B 2.01B 1.26B 4.6B 963M 34.31B 10.56B -9.64B 11.19B 9.93B 15.16B 6.9B 16.88B 11.68B 8.55B 2.15B 5.72B
Other Investing Acitivies
-9M 299M 12M 6M -19M 1M 15M 350M -524M -18M 9M 3.85B -77M -13M 64M -298M -235M 163M
Investing Cash Flow
3.95B 3.27B -1.62B -2.06B 4.6B 1.73B -11B 888M -25.48B 3.31B -4.41B -627M -11.31B 567M -2.59B -10.08B -8.14B -1.75B
Debt Repayment
-731M -2.43B -2.72B -2.25B -16M -2.17B 7.78B -1.43B 29.63B -32M -2.78B -3.52B 4.61B -1.83B -1.36B 759M -474M -25M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2B n/a n/a n/a n/a
Dividend Paid
-2.44B -2.44B -2.38B -2.38B -2.38B -2.37B -2.31B -2.31B -2.31B -2.3B -2.25B -2.25B -2.24B -2.25B -2.19B -2.19B -2.18B -2.17B
Other Financial Acitivies
-21M -356M -14M -6M -63M -386M -18M -37M -141M -436M 7M 5M 153M -500M 201M 325M 100M -610M
Financial Cash Flow
-3.2B -5.23B -5.11B -4.64B -2.46B -4.93B 5.44B -3.78B 27.17B -2.77B -5.01B -5.76B 2.52B -6.58B -3.35B -1.1B -2.56B -2.81B
Net Cash Flow
213M 374M -45M 40M 343M -2.14B -295M 535M 476M 1.75B -870M -486M -690M 530M -22M -384M 609M -16M
Free Cash Flow
-1.2B 1.77B 5.8B 6.06B -2.42B 386M 4.2B 2.65B -2.12B 74M 7.58B 5.13B 7.42B 5.9B 4.92B 10.21B 10.76B 3.98B